Videoendoscopic inguinal lymphadenectomy versus radical open dissection (VELRAD) in patients with male genital cancer: a clinical trial update
dc.contributor.author | Tang, S. | |
dc.contributor.author | Pang, K. H. | |
dc.contributor.author | Alnajjar, H. M. | |
dc.contributor.author | Ayres, B. | |
dc.contributor.author | Kumar, V. | |
dc.contributor.author | Parnham, Arie S | |
dc.contributor.author | Muneer, A. | |
dc.date.accessioned | 2023-03-20T15:44:02Z | |
dc.date.available | 2023-03-20T15:44:02Z | |
dc.date.issued | 2023 | en |
dc.identifier.citation | Tang S, Pang KH, Alnajjar HM, Ayres B, Kumar V, Parnham A, et al. Videoendoscopic Inguinal Lymphadenectomy Versus Radical Open Dissection (VELRAD) in Patients with Male Genital Cancer: A Clinical Trial Update. Eur Urol Focus. 2023 Feb 14. PubMed PMID: 36797170. Epub 2023/02/17. eng. | en |
dc.identifier.pmid | 36797170 | en |
dc.identifier.doi | 10.1016/j.euf.2023.01.018 | en |
dc.identifier.uri | http://hdl.handle.net/10541/626071 | |
dc.description.abstract | VELRAD is the first multicentre feasibility randomised controlled trial comparing videoendoscopic radical inguinal lymphadenectomy versus open dissection for male genital cancer. We have randomised nine patients so far in our attempt to identify the best approach to inguinal lymph node dissection. | en |
dc.language.iso | en | en |
dc.relation.url | https://dx.doi.org/10.1016/j.euf.2023.01.018 | en |
dc.title | Videoendoscopic inguinal lymphadenectomy versus radical open dissection (VELRAD) in patients with male genital cancer: a clinical trial update | en |
dc.type | Article | en |
dc.contributor.department | University College London Hospitals NHS Foundation Trust, London, UK | en |
dc.identifier.journal | European Urology Focus | en |
dc.description.note | en] |